Blood Advances (May 2025)
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
- Reid Shaw,
- James J. Yoon,
- Hannah Johnston,
- Marta B. Davidson,
- Alexa J. Siddon,
- Rory M. Shallis,
- Evan C. Chen,
- Madelyn Burkart,
- Timothy S. Oh,
- Sunil G. Iyer,
- Ellen Madarang,
- Chandrasekar Muthiah,
- Joshua Kassner,
- Raajit K. Rampal,
- Guru Subramanian Guru Murthy,
- Terrence Bradley,
- Yasmin Abaza,
- Jacqueline S. Garcia,
- Vikas Gupta,
- Kristen M. Pettit,
- Olatoyosi Odenike,
- Anand A. Patel
Affiliations
- Reid Shaw
- Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
- James J. Yoon
- Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
- Hannah Johnston
- Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
- Marta B. Davidson
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
- Alexa J. Siddon
- Departments of Laboratory Medicine and Pathology, Yale School of Medicine, New Haven, CT
- Rory M. Shallis
- Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
- Evan C. Chen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
- Madelyn Burkart
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
- Timothy S. Oh
- Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
- Sunil G. Iyer
- Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
- Ellen Madarang
- Department of Pharmacy, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
- Chandrasekar Muthiah
- Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI
- Joshua Kassner
- Division of Hematology and Medical Oncology, Weill Department of Medicine, Cornell University, Ithaca, NY
- Raajit K. Rampal
- Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
- Guru Subramanian Guru Murthy
- Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
- Terrence Bradley
- Department of Pharmacy, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
- Yasmin Abaza
- Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
- Jacqueline S. Garcia
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
- Vikas Gupta
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
- Kristen M. Pettit
- Division of Hematology and Medical Oncology, Department of Internal Medicine, University of Michigan Medical School, Michigan Medicine, Ann Arbor, MI
- Olatoyosi Odenike
- Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
- Anand A. Patel
- Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL; Correspondence: Anand A. Patel, Section of Hematology/Oncology, University of Chicago, 5841 S Maryland Ave, MC 2115, Chicago, IL 60637;
- Journal volume & issue
-
Vol. 9,
no. 10
pp. 2453 – 2457